{"retracted":true,"title":"Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin.","url":"http://doi.org/10.1007/s10549-014-3068-6","journal":"Breast cancer research and treatment","update":"retracted"}
